Arkolith/Insider Trading/SMMT/Form 4

Duggan Robert W

Co-Chief Executive Officer, Director, 10% OwnerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Jun 12, 2026
Net Buying
Open-Market Buys
$50.0M
Open-Market Sells
$0
Net Open-Market Flow
$50.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2026Buy(P)3.8M$13.12$50.0M573.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001055919-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML